Friday, 16 October 2026European Markets

LDC And MALTERIES FCO-BEL. Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - ldc (loup.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
ldc (loup.pa) €136.00 1.81% 15.12%
malteries fco-bel. (malt.pa) €615.00 0.61% 14.38%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ldc (loup.pa)

1.81% forward dividend yield and 15.12% return on equity

l.d.c. s.a. produces and sells poultry and processed products in france and internationally. the company also offers ready-cooked dishes, pizzas, pancakes and biscuits, and sandwiches, as well as fresh and frozen products. it offers its products under the le gaulois, maître coq, loué, marie, poule & toque, nature & respect, drosed, goldenfood, and doux brands. the company was founded in 1909 and is based in sablé-sur-sarthe, france.

earnings per share

as for profitability, ldc has a trailing twelve months eps of €16.44.

pe ratio

ldc has a trailing twelve months price to earnings ratio of 8.27. meaning, the purchaser of the share is investing €8.27 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.12%.

sales growth

ldc's sales growth for the current quarter is negative 5%.

volatility

ldc's last week, last month's, and last quarter's current intraday variation average was a negative 0.92%, a positive 0.40%, and a positive 1.34%.

ldc's highest amplitude of average volatility was 2.26% (last week), 1.38% (last month), and 1.34% (last quarter).

dividend yield

as maintained by morningstar, inc., the next dividend payment is on aug 28, 2023, the estimated forward annual dividend rate is 2.7 and the estimated forward annual dividend yield is 1.81%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ldc's stock is considered to be overbought (>=80).

more news about ldc.

2. malteries fco-bel. (malt.pa)

0.61% forward dividend yield and 14.38% return on equity

malteries franco-belges société anonyme engages in the production and sale of malt primarily for brewers in france and internationally. it trades in barley. the company is headquartered in nogent-sur-seine, france. malteries franco-belges société anonyme is a subsidiary of malteries soufflet sas.

earnings per share

as for profitability, malteries fco-bel. has a trailing twelve months eps of €54.87.

pe ratio

malteries fco-bel. has a trailing twelve months price to earnings ratio of 11.21. meaning, the purchaser of the share is investing €11.21 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.38%.

more news about malteries fco-bel..

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
LDC And MALTERIES FCO-BEL. Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector. | ViaNews EU